keyword
Keywords pharmaceutical development and...

pharmaceutical development and technology

https://read.qxmd.com/read/38652378/a-breakthrough-in-phytochemical-profiling-ultra-sensitive-surface-enhanced-raman-spectroscopy-platform-for-detecting-bioactive-components-in-medicinal-and-edible-plants
#1
JOURNAL ARTICLE
Chunjuan Yang, Yue Zhao, Shuang Jiang, Xiaomeng Sun, Xiaotong Wang, Zhibin Wang, Yanli Wu, Jing Wu, Yang Li
A perennial challenge in harnessing the rich biological activity of medicinal and edible plants is the accurate identification and sensitive detection of their active compounds. In this study, an innovative, ultra-sensitive detection platform for plant chemical profiling is created using surface-enhanced Raman spectroscopy (SERS) technology. The platform uses silver nanoparticles as the enhancing substrate, excess sodium borohydride prevents substrate oxidation, and methanol enables the tested molecules to be better adsorbed onto the silver nanoparticles...
April 23, 2024: Mikrochimica Acta
https://read.qxmd.com/read/38649550/third-generation-solid-dispersion-based-formulation-of-novel-anti-tubercular-agent-exhibited-improvement%C3%A2-in-solubility-dissolution-and-biological-activity
#2
JOURNAL ARTICLE
Gourav Paudwal, Rigzin Dolkar, Summaya Perveen, Rashmi Sharma, Parvinder Pal Singh, Prem N Gupta
The long treatment period and development of drug resistance in tuberculosis (TB) necessitates the discovery of new anti-tubercular agents. The drug discovery program of the institute leads to the development of an anti-tubercular lead (IIIM-019), which is an analogue of nitrodihydroimidazooxazole and exhibited promising anti-tubercular action. However, IIIM-019 displays poor aqueous solubility (1.2 µg/mL), which demands suitable dosage form for its efficient oral administration. In the present study, third generation solid dispersion-based formulation was developed to increase the solubility and dissolution of IIIM-019...
April 22, 2024: AAPS Journal
https://read.qxmd.com/read/38649099/modeling-an-evaluation-of-the-efficacy-of-the-novel-neuroanalgesic-drug-mirogabalin-for-diabetic-peripheral-neuropathic-pain-and-postherpetic-neuralgia-therapy
#3
JOURNAL ARTICLE
Li-Mian Hong, Jian-Min Liu, Lei Lin, Chun-Chun Huang, Rui Chen, Wei-Wei Lin
Diabetic peripheral neuropathic pain (DPNP) and postherpetic neuralgia (PHN) are challenging and often intractable complex medical conditions, with a substantial impact on the quality of life. Mirogabalin, a novel voltage-gated Ca2+ channel α2δ ligand, was approved for the indication of DPNP and PHN. However, the time course of effects has not yet been clarified.We aimed to establish pharmacodynamic and placebo effect models of mirogabalin and pregabalin in DPNP and PHN, and to quantitatively compare the efficacy characteristics (maximum efficacy, onset time, and other pharmacodynamic parameters) and safety of mirogabalin and pregabalin...
April 20, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38648941/navigating-the-future-microfluidics-charting-new-routes-in-drug-delivery
#4
REVIEW
Mohammad Mohammadi, Syamand Ahmed Qadir, Aryan Mahmood Faraj, Osama Hamid Shareef, Hassan Mahmoodi, Fatemeh Mahmoudi, Sajad Moradi
Microfluidics has emerged as a transformative force in the field of drug delivery, offering innovative avenues to produce a diverse range of nano drug delivery systems. Thanks to its precise manipulation of small fluid volumes and its exceptional command over the physicochemical characteristics of nanoparticles, this technology is notably able to enhance the pharmacokinetics of drugs. It has initiated a revolutionary phase in the domain of drug delivery, presenting a multitude of compelling advantages when it comes to developing nanocarriers tailored for the delivery of poorly soluble medications...
April 20, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38648904/generation-and-characterization-of-cytochrome-p450-3a74-crispr-cas9-knockout-bovine-foetal-hepatocyte-cell-line-bfh12
#5
JOURNAL ARTICLE
Silvia Iori, Caterina D'Onofrio, Nihay Laham-Karam, Isidore Mushimiyimana, Lorena Lucatello, Ludovica Montanucci, Rosa Maria Lopparelli, Federico Bonsembiante, Francesca Capolongo, Marianna Pauletto, Mauro Dacasto, Mery Giantin
In human, the cytochrome P450 3A (CYP3A) subfamily of drug-metabolizing enzymes (DMEs) is responsible for a significant number of phase I reactions, with the CYP3A4 isoform superintending the hepatic and intestinal metabolism of diverse endobiotic and xenobiotic compounds. The CYP3A4-dependent bioactivation of chemicals may result in hepatotoxicity and trigger carcinogenesis. In cattle, four CYP3A genes (CYP3A74, CYP3A76, CYP3A28 and CYP3A24) have been identified. Despite cattle being daily exposed to xenobiotics (e...
April 20, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38648873/a-roadmap-towards-a-human-centric-safety-assessment-of-advanced-therapy-medicinal-products
#6
JOURNAL ARTICLE
Hsiao-Tzu Chien, Victoria C de Leeuw, Joantine C J van Esterik, Frans G M Russel, Anne S Kienhuis, Peter T Theunissen, Peter van Meer
Advanced therapy medicinal products (ATMPs) are among the most complex pharmaceuticals with high human specificity. Species differences severely limit the clinical relevance of in vivo data. We conducted interviews with stakeholders involved in ATMP development about their perspective on the use of in vivo studies, the perceived hurdles and associated potential solutions regarding non-clinical development of ATMPs. In total, 17 stakeholders from 9 different countries were interviewed. A workshop was held with key stakeholders to further discuss major topics identified from the interviews...
April 20, 2024: Regulatory Toxicology and Pharmacology: RTP
https://read.qxmd.com/read/38648728/research-strategies-of-small-molecules-as-chemotherapeutics-to-overcome-multiple-myeloma-resistance
#7
REVIEW
Jin Yang, Yan-Cheng Yu, Zi-Xuan Wang, Qing-Qing Li, Ning Ding, Xue-Jiao Leng, Jiao Cai, Meng-Yuan Zhang, Jing-Jing Wang, Yun Zhou, Tian-Hua Wei, Xin Xue, Wei-Chen Dai, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Multiple myeloma (MM), a cancer of plasma cells, is the second most common hematological malignancy which is characterized by aberrant plasma cells infiltration in the bone marrow and complex heterogeneous cytogenetic abnormalities. Over the past two decades, novel treatment strategies such as proteasome inhibitors, immunomodulators, and monoclonal antibodies have significantly improved the relative survival rate of MM patients. However, the development of drug resistance results in the majority of MM patients suffering from relapse, limited treatment options and uncontrolled disease progression after relapse...
April 20, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38647989/reaction-strategies-for-the-meta-selective-functionalization-of-pyridine-through-dearomatization
#8
REVIEW
Jie Lei, Zhi-Gang Xu
The pyridine moiety is a crucial structural component in various pharmaceuticals. While the direct ortho- and para-functionalization of pyridines is relatively straightforward, the meta-selective C-H functionalization remains a significant challenge. This review highlights dearomatization strategies as a key area of interest in expanding the application of meta-C-H functionalization of pyridines. Dearomatization enables the meta-functionalization through various catalytic methods that directly generate dearomatization products, and some products can be rearomatized back to pyridine derivatives...
April 22, 2024: Molecular Diversity
https://read.qxmd.com/read/38647164/access-in-all-areas-a-round-up-of-developments-in-market-access-and-health-technology-assessment-part-4
#9
JOURNAL ARTICLE
Alice Beattie, Catrin Treharne, Sreeram V Ramagopalan
In this latest update, we look at recent developments in market access including the pricing agreement of Libmeldy® by the Beneluxa Initiative, the financial impact of managed entry agreements in Italy and the restructuring of Agenzia Italiana del Farmaco (AIFA). We also highlight the collaboration between FINOSE and the New Expensive Drug (NED) section of the Nordic Pharmaceutical Forum.
April 22, 2024: Journal of Comparative Effectiveness Research
https://read.qxmd.com/read/38645432/advances-in-tissue-engineering-and-biofabrication-for-in-vitro-skin-modeling
#10
JOURNAL ARTICLE
Sarah C Wistner, Layla Rashad, Gymama Slaughter
The global prevalence of skin disease and injury is continually increasing, yet conventional cell-based models used to study these conditions do not accurately reflect the complexity of human skin. The lack of inadequate in vitro modeling has resulted in reliance on animal-based models to test pharmaceuticals, biomedical devices, and industrial and environmental toxins to address clinical needs. These in vivo models are monetarily and morally expensive and are poor predictors of human tissue responses and clinical trial outcomes...
November 2023: Bioprinting
https://read.qxmd.com/read/38643941/development-of-a-dry-powder-insufflation-device-with-application-in-in-vitro-cell-based-assays-in-the-context-of-respiratory-delivery
#11
JOURNAL ARTICLE
Jorge F Pontes, Hermínio P Diogo, Eusébio Conceição, Maria P Almeida, Rui M Borges Dos Santos, Ana Grenha
Research on pharmaceutical dry powders has been increasing worldwide, along with increased therapeutic strategies for an application through the pulmonary or the nasal routes. In vitro methodologies and tests that mimic the respiratory environment and the process of inhalation itself are, thus, essential. The literature frequently reports cell-based in vitro assays that involve testing the dry powders in suspension. This experimental setting is not adequate, as both the lung and the nasal cavity are devoid of abundant liquid...
April 19, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38643940/the-allostery-and-modification-of-hghrh-molecules-and-specific-dimer-produced-significant-fertility-effect-by-proliferating-and-activating-in-situ-ovarian-mesenchymal-stem-cells
#12
JOURNAL ARTICLE
Xu-Dong Zhang, Qun Luo, Yan Du, Li Yang, Li-Cheng Yu, Lan Feng, Dan Rao, Jing-Xuan Tang, Hong-Mei Tan, Xiao-Yuan Guo, Song-Shan Tang, Tao Liu, Feng Yue, Hui-Xian Huang
The negative coordination of growth hormone secretagogue receptor (GHS-R) and growth hormone-releasing hormone receptor (GHRH-R) involves in the repair processes of cellular injury. The allosteric U- or H-like modified GHRH dimer Grinodin and 2Y were comparatively evaluated in normal Kunming mice and hamster infertility models induced by CPA treatment. 1-3-9 µg of Grinodin or 2Y per hamster stem-cell-exhaustion model was subcutaneously administered once a week, respectively inducing 75-69-46 or 45-13-50% of birth rates...
April 19, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38643841/cell-membrane-coated-nanoparticles-for-targeting-carcinogenic-bacteria
#13
REVIEW
Lei Sun, Dan Wang, Kailin Feng, Jiayuan Alex Zhang, Weiwei Gao, Liangfang Zhang
The etiology of cancers is multifactorial, with certain bacteria established as contributors to carcinogenesis. As the understanding of carcinogenic bacteria deepens, interest in cancer treatment through bacterial eradication is growing. Among emerging antibacterial platforms, cell membrane-coated nanoparticles (CNPs), constructed by enveloping synthetic substrates with natural cell membranes, exhibit significant promise in overcoming challenges encountered by traditional antibiotics. This article reviews recent advancements in developing CNPs for targeting carcinogenic bacteria...
April 19, 2024: Advanced Drug Delivery Reviews
https://read.qxmd.com/read/38643811/prolonged-delivery-of-hiv-1-vaccine-nanoparticles-from-hydrogels
#14
JOURNAL ARTICLE
Raphael Mietzner, Clara Barbey, Heike Lehr, Christian E Ziegler, David Peterhoff, Ralf Wagner, Achim Goepferich, Miriam Breunig
Immunization is a straightforward concept but remains for some pathogens like HIV-1 a challenge. Thus, new approaches towards increasing the efficacy of vaccines are required to turn the tide. There is increasing evidence that antigen exposure over several days to weeks induces a much stronger and more sustained immune response compared to traditional bolus injection, which usually leads to antigen elimination from the body within a couple of days. Therefore, we developed a poly(ethylene) glycol (PEG) hydrogel platform to investigate the principal feasibility of a sustained release of antigens to mimic natural infection kinetics...
April 19, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38643808/cracking-the-code-spatial-heterogeneity-as-the-missing-piece-for-modeling-granular-fluidized-bed-drying
#15
JOURNAL ARTICLE
Tuur Vandeputte, Michael Ghijs, Thomas De Beer, Ingmar Nopens
Pharmaceutical twin-screw wet granulation is a multifaceted and intricate process pivotal to drug product development. Accurate modeling of this process is indispensable for optimizing manufacturing parameters and ensuring product quality. The fluid bed dryer, an integral component of this granulation process, significantly influences the granular critical quality attributes. This study builds upon prior research by integrating experimental findings on granule segregation during fluid bed drying into an existing compartmental model, enhancing its predictive capabilities...
April 19, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38643642/evidence-of-deviations-between-experimental-and-empirical-mixing-lengths-multi-discharge-field-tests-in-an-arid-river-system
#16
JOURNAL ARTICLE
Aashish Khandelwal, Tzion Castillo, Ricardo González-Pinzón
Despite advances in wastewater treatment plant (WWTP) efficiencies, multiple contaminants of concern, such as microplastics, pharmaceuticals, and per- and poly-fluoroalkyl substances (PFAS) remain largely untreated near discharge points and can be highly concentrated before they are fully mixed within the receiving river. Environmental agencies enforce mixing zone permits for the temporary exceedance of water quality parameters beyond targeted control levels under the assumption that contaminants are well-mixed and diluted downstream of mixing lengths, which are typically quantified using empirical equations derived from one-dimensional transport models...
April 17, 2024: Water Research
https://read.qxmd.com/read/38642710/polarised-views-and-fretting-about-probe-modulation-assays-learning-from-high-throughput-screening
#17
JOURNAL ARTICLE
Alice Lanne, Catherine Bardelle, Gareth Davies, Antonia Turberville, Hannah Semple, Rachel Moore, Geoffrey A Holdgate
Fluorescent probe modulation assays are a widely used approach to monitor displacement or stabilisation of fluorescently labelled tool ligands by test compounds. These assays allow an optical read-out of probe-receptor binding and can be used to detect compounds that compete with the labelled ligand, either directly or indirectly. Probes for both orthosteric and allosteric sites are often employed. The method can also be used to identify test compounds that may stabilise the ternary complex, offering an opportunity to discover novel molecular glues...
April 18, 2024: SLAS Discovery
https://read.qxmd.com/read/38642703/targeting-eed-as-a-key-prc2-complex-mediator-toward-novel-epigenetic-therapeutics
#18
REVIEW
Qichao Bao, Anil Kumar, Daqing Wu, Jia Zhou
EED within the PRC2 complex is crucial for chromatin regulation, particularly in tumor development, such that its inhibition is a promising epigenetic therapeutic strategy. Significant advancement in PRC2 inhibitor development has been achieved with an approved EZH2 inhibitor in the market and with others in clinical trials. However, current EZH2 inhibitors are limited to specific blood cancers and encounter therapeutic resistance. EED stabilizes PRC2 and enhances its activity through unique allosteric mechanisms, thereby acting as both a scaffold protein and a recognizer of H3K27me3 making it an attractive drug target...
April 18, 2024: Drug Discovery Today
https://read.qxmd.com/read/38642700/the-present-state-and-challenges-of-active-learning-in-drug-discovery
#19
REVIEW
Lei Wang, Zhenran Zhou, Xixi Yang, Shaohua Shi, Xiangxiang Zeng, Dongsheng Cao
Active learning (AL) is an iterative feedback process that efficiently identifies valuable data within vast chemical space, even with limited labeled data. This characteristic renders it a valuable approach to tackle the ongoing challenges faced in drug discovery, such as the ever-expanding explore space and the limitations of labeled data. Consequently, AL is increasingly gaining prominence in the field of drug development. In this paper, we comprehensively review the application of AL at all stages of drug discovery, including compounds-target interaction prediction, virtual screening, molecular generation and optimization, as well as molecular properties prediction...
April 18, 2024: Drug Discovery Today
https://read.qxmd.com/read/38642620/statistical-data-pre-treatment-for-residence-time-distribution-studies-in-pharmaceutical-manufacturing
#20
JOURNAL ARTICLE
Pooja Bhalode, Sonia M Razavi, Huayu Tian, Andres Roman-Ospino, James Scicolone, Gerardo Callegari, Atul Dubey, Abdollah Koolivand, Scott Krull, Thomas O'Connor, Fernando J Muzzio, Marianthi G Ierapetritou
Residence time distribution (RTD) method has been widely used in the pharmaceutical manufacturing for understanding powder dynamics within unit operations and continuous integrated manufacturing lines. The dynamics thus captured is then used to develop predictive models for unit operations and important RTD-based applications ensuring product quality assurance. Despite thorough efforts in tracer selection, data acquisition, and calibration model development to obtain tracer concentration profiles for RTD studies, there can exist significant noise in these profiles...
April 18, 2024: International Journal of Pharmaceutics
keyword
keyword
96063
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.